Drugs / Fluticaosne Propionate 500mcg/Salmeterol 50mcg
last change Oct 2011 re-read 2 minutes ago

Fluticaosne Propionate 500mcg/Salmeterol 50mcg

Developed for
chronic obstructive pulmonary disease

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01342913 Comparator Feb → Oct 2011 chronic obstructive pulmonary disease GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Fluticaosne Propionate 500mcg/Salmeterol 50mcg ClinicalTrials.gov intervention name — accepted as the source's own label NCT01342913